NRNP 6665 FINAL TEST 2025 / WITH 80 AUTHENTIC
QUESTIONS AND ANSWERS / 100% CORRECT /
GRADED A+
QUESTION 1:
Christine is a 9-year-old female who presents for care after having
been placed in the local foster care system. She has been in and
out of foster care for the last 4 years after her parents were killed in
an automobile accident. Christine has been placed in a variety of
homes and residential care facilities. The PMHNP recognizes that
Christine is at high risk for:
A. Dissociative disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
- ANSWER:
D. Attachment disorder
QUESTION 2:
Caylee is a 5-year-old girl who is referred for evaluation by child
protective services. She was recently removed from her biological
family and placed in foster care, as her home environment was
reportedly unsafe due to conditions of extreme neglect. Her foster
mother reports that Caylee is very quiet and withdrawn and always
appears sad and disinterested in her surroundings; however, she
becomes very irritable when anything unexpected or unplanned
occurs. The foster mother became very concerned when it
appeared that Caylee was hallucinating. The PMHNP considers
that:
A. Caylee is at high risk for suicide and precautions should be
taken
B. The hallucinations are consistent with brief psychotic disorder
or schizophrenia
C. The history and reported symptoms are typical of depressive
disorder in young children
D. This is a common situation when prepubertal children are
removed from the biological parents regardless of how
dysfunctional they are
-ANSWER:
,C. The history and reported symptoms are typical of depressive
disorder in young children
QUESTION: 3
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and involved in
her care, and Debi has achieved remission 2 months after
beginning treatment with a combination of pharmacotherapy and
cognitive behavioral therapy. While counseling Debi's parents
about important issues in management, the PMHNP advises that:
A. There is a > 50% likelihood that Debi's younger sibling will
develop depressive symptoms
B. The mean length of major depressive episode in adolescents is 4
months
C. 20 to 40% of adolescents who have major depressive disorder
will develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term
pharmacologic management to prevent relapses
- ANSWER:
C. 20 to 40% of adolescents who have major depressive disorder
will develop bipolar I within 5 years
QUESTION: 4
In which demographic is depression twice as prevalent in girls as
compared to boys?
A. Preschoolers
B. School aged
C. Adolescents
D. All children
-ANSWER:
C. Adolescents
QUESTION: 5
Which of the following is not a true statement with respect to
confidentiality of the child or adolescent client?
A. The PMHNP should not be concerned with consent for
disclosure when child abuse or maltreatment has occurred.
B. In 1979, the American Psychiatric Association (APA) stated that
children 12 years of age or older can give consent for disclosure.
C. The American Academy of Child and Adolescent Psychiatry
(AACAP) Code of Ethics states that consent is not required for
disclosure.
,D. Regardless of code or position statement by any organization,
the best approach is when the child and PMHNP agree on
disclosure.
-ANSWER:
C. The American Academy of Child and Adolescent Psychiatry
(AACAP) Code of Ethics states that consent is not required for
disclosure.
QUESTION: 6
Andrew is a 14-year-old male who is being managed for bipolar I
disorder. He was started on lithium 6 weeks ago and has achieved
a serum level of 1.1 mEq/L according to his most recent blood
work. Andrew says he doesn't feel any different, but both his
parents and teachers report improvement in his mood. He has been
more stable, is getting along better with friends and siblings, and is
even more interested in his schoolwork. The PMHNP plans to
maintain Andrew on this medication and knows that he will need
which of the following ongoing laboratory assessments?
A. Complete blood count, thyroid function tests, and serum
calcium
B. Liver function tests, complete blood count, and 12-lead
electrocardiogram
C. White blood cell differential, fasting glucose, and fasting lipid
profile
D. Comprehensive metabolic panel, complete blood count, and
thyroid function tests
-ANSWER:
A. Complete blood count, thyroid function tests, and serum
calcium
QUESTION: 7
The therapeutic outcomes for children with disorders of written
expression are most favorable when they are characterized by:
A. Concomitant pharmacotherapy with a psychostimulant to
promote attention and focus
B. Multimodal therapy to include group interaction with peer-to-
peer feedback on writing samples
C. variety of tutors who will offer a variety of writing techniques,
composition strategies, and critiques
D. Intensive, continuous administration of individually tailored,
one-on-one expressive and creative writing therapy
-ANSWER:
, D. Intensive, continuous administration of individually tailored,
one-on-one expressive and creative writing therapy
Aripiprazole
abilify/ antipsychotic (atypical)
S/sx: drowsiness
Risperidone
Atypical antipsychotic causing high prolactin levels
with lots of extrapyramidal SE
Amphetamine IR
Adderall
CNS Stimulant
Amphetamine XR
Adderall (XR) CNS Stimulant
Dextroamphetamine
CNS stimulant
Mech: Inc catecholamines at the synaptic cleft, especially NE and
dopamine.
Use: ADHD, narcolepsy, apetite control
Atomoxetine (Strattera)
- BBW
> Risk of suicidal ideation; monitor for suicidal thinking or
behavior, worsening, or unusual behavior
- Contraindications
> Glaucoma, pheochromocytoma, MAO I use within past 14 days
- Warning
> Rare, but severe hepatotoxicity (most within 120 days of start of
treatment)
SE
> Headache, insomnia, somnolence, dry mouth, nausea, abdominal
pain, decrease in appetite, nausea, etc.
> Priapism
NOTE
> do not open capsule - irritant
> CYPD 2D6 substrate
> watch out for LIVER PROBLEMS
Clonidine
alpha 2 agonist
-treatment for hypertension and opioid withdrawal
-side effects of bradycardia and hypotension
Dexmethylphenidate
ADHD stimulant
Guanfacine Hydrochloride
QUESTIONS AND ANSWERS / 100% CORRECT /
GRADED A+
QUESTION 1:
Christine is a 9-year-old female who presents for care after having
been placed in the local foster care system. She has been in and
out of foster care for the last 4 years after her parents were killed in
an automobile accident. Christine has been placed in a variety of
homes and residential care facilities. The PMHNP recognizes that
Christine is at high risk for:
A. Dissociative disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
- ANSWER:
D. Attachment disorder
QUESTION 2:
Caylee is a 5-year-old girl who is referred for evaluation by child
protective services. She was recently removed from her biological
family and placed in foster care, as her home environment was
reportedly unsafe due to conditions of extreme neglect. Her foster
mother reports that Caylee is very quiet and withdrawn and always
appears sad and disinterested in her surroundings; however, she
becomes very irritable when anything unexpected or unplanned
occurs. The foster mother became very concerned when it
appeared that Caylee was hallucinating. The PMHNP considers
that:
A. Caylee is at high risk for suicide and precautions should be
taken
B. The hallucinations are consistent with brief psychotic disorder
or schizophrenia
C. The history and reported symptoms are typical of depressive
disorder in young children
D. This is a common situation when prepubertal children are
removed from the biological parents regardless of how
dysfunctional they are
-ANSWER:
,C. The history and reported symptoms are typical of depressive
disorder in young children
QUESTION: 3
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and involved in
her care, and Debi has achieved remission 2 months after
beginning treatment with a combination of pharmacotherapy and
cognitive behavioral therapy. While counseling Debi's parents
about important issues in management, the PMHNP advises that:
A. There is a > 50% likelihood that Debi's younger sibling will
develop depressive symptoms
B. The mean length of major depressive episode in adolescents is 4
months
C. 20 to 40% of adolescents who have major depressive disorder
will develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term
pharmacologic management to prevent relapses
- ANSWER:
C. 20 to 40% of adolescents who have major depressive disorder
will develop bipolar I within 5 years
QUESTION: 4
In which demographic is depression twice as prevalent in girls as
compared to boys?
A. Preschoolers
B. School aged
C. Adolescents
D. All children
-ANSWER:
C. Adolescents
QUESTION: 5
Which of the following is not a true statement with respect to
confidentiality of the child or adolescent client?
A. The PMHNP should not be concerned with consent for
disclosure when child abuse or maltreatment has occurred.
B. In 1979, the American Psychiatric Association (APA) stated that
children 12 years of age or older can give consent for disclosure.
C. The American Academy of Child and Adolescent Psychiatry
(AACAP) Code of Ethics states that consent is not required for
disclosure.
,D. Regardless of code or position statement by any organization,
the best approach is when the child and PMHNP agree on
disclosure.
-ANSWER:
C. The American Academy of Child and Adolescent Psychiatry
(AACAP) Code of Ethics states that consent is not required for
disclosure.
QUESTION: 6
Andrew is a 14-year-old male who is being managed for bipolar I
disorder. He was started on lithium 6 weeks ago and has achieved
a serum level of 1.1 mEq/L according to his most recent blood
work. Andrew says he doesn't feel any different, but both his
parents and teachers report improvement in his mood. He has been
more stable, is getting along better with friends and siblings, and is
even more interested in his schoolwork. The PMHNP plans to
maintain Andrew on this medication and knows that he will need
which of the following ongoing laboratory assessments?
A. Complete blood count, thyroid function tests, and serum
calcium
B. Liver function tests, complete blood count, and 12-lead
electrocardiogram
C. White blood cell differential, fasting glucose, and fasting lipid
profile
D. Comprehensive metabolic panel, complete blood count, and
thyroid function tests
-ANSWER:
A. Complete blood count, thyroid function tests, and serum
calcium
QUESTION: 7
The therapeutic outcomes for children with disorders of written
expression are most favorable when they are characterized by:
A. Concomitant pharmacotherapy with a psychostimulant to
promote attention and focus
B. Multimodal therapy to include group interaction with peer-to-
peer feedback on writing samples
C. variety of tutors who will offer a variety of writing techniques,
composition strategies, and critiques
D. Intensive, continuous administration of individually tailored,
one-on-one expressive and creative writing therapy
-ANSWER:
, D. Intensive, continuous administration of individually tailored,
one-on-one expressive and creative writing therapy
Aripiprazole
abilify/ antipsychotic (atypical)
S/sx: drowsiness
Risperidone
Atypical antipsychotic causing high prolactin levels
with lots of extrapyramidal SE
Amphetamine IR
Adderall
CNS Stimulant
Amphetamine XR
Adderall (XR) CNS Stimulant
Dextroamphetamine
CNS stimulant
Mech: Inc catecholamines at the synaptic cleft, especially NE and
dopamine.
Use: ADHD, narcolepsy, apetite control
Atomoxetine (Strattera)
- BBW
> Risk of suicidal ideation; monitor for suicidal thinking or
behavior, worsening, or unusual behavior
- Contraindications
> Glaucoma, pheochromocytoma, MAO I use within past 14 days
- Warning
> Rare, but severe hepatotoxicity (most within 120 days of start of
treatment)
SE
> Headache, insomnia, somnolence, dry mouth, nausea, abdominal
pain, decrease in appetite, nausea, etc.
> Priapism
NOTE
> do not open capsule - irritant
> CYPD 2D6 substrate
> watch out for LIVER PROBLEMS
Clonidine
alpha 2 agonist
-treatment for hypertension and opioid withdrawal
-side effects of bradycardia and hypotension
Dexmethylphenidate
ADHD stimulant
Guanfacine Hydrochloride
